Nostrum Biodiscovery
Innovation Partner
Nostrum Biodiscovery is a spin-off of the Barcelona Supercomputing Center and the Institute for Research in Biomedicine, devoted to the development and exploitation of state of the art, AI- based computational biochemistry tools for the design of next-generation therapies and biotechnology products.
The Nucleic Acids department performs projects by Targeting RNA, designing different types of oligonucleotides, RNA vaccines and Splicing modulators. Currently is developing XNA-Hub, a comprehensive global database and molecular modeling platform aimed at streamlining nucleic acids research.
Hongene Biotech
Exhibition Partner
Established in 1998, Hongene Biotech has been specialized in the production of nucleic acid raw materials for more than 25 years, covering nucleosides and modified nucleosides, nucleotides, phosphonamidites, GalNAc delivery molecules and enzymes. The annual capacity of phosphonamidites is 58 tons and nucleoside triphosphates is 54,000 liters (equivalent of 1.05 billion doses of mRNA vaccines). To date, Hongene has over 1,600 employees globally with over 400 R&D staff. Hongene brand is highly recognized by major pharmaceutical companies and biotech companies developing mRNA and oligonucleotide drugs. Hongene's products have entered almost all nucleic acid drug pipelines worldwide. During the Covid19 pandemic, Hongene was the largest supplier of raw materials used in billions of mRNA COVID-19 vaccines. Currently, the company has established end-to-end mRNA CDMO capability, provide one-stop shopping from raw materials to final product, supporting clients from preclinical research to commercialization.
Chemgenes Corporation
Exhibition Partner
ChemGenes, an ISO 9001 certified company established in 1981, is the industry leader in manufacturing oligonucleotide synthesis reagents and has consistently provided the highest quality phosphoramidites and solid supports in the market. Our facility, just outside of Boston/Cambridge Massachusetts USA, is setup for bulk manufacturing of therapeutic grade phosphoramidite and solid support DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. In addition, ChemGenes is expanding its custom oligonucleotide synthesis department specializing in the manufacture of ASOs, siRNA, gRNA, gapmers, aptamers, DNA based probes, and superior quality beads for Single Cell mRNA sequencing applications using Drop-Seq, Slide-seq, and Seq-Well methods. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
Wave Life Sciences
Event Partner
Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeted modalities includes RNA editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for sustainably delivering candidates that optimally address disease biology. Visit wavelifesciences.com for more.